Conducting placebo controlled randomized trials
نویسندگان
چکیده
منابع مشابه
Blindness in Randomized Controlled Trials
In combination with randomization, blinding or masking is an important factor in randomized controlled trials (RCTs), particularly in trials that assess therapeutic effects. Here an attempt is made to explain blindness and why it is important. In clinical trials, blinding is defined as the condition imposed on a study in which study participants, health care providers and assessors collecting o...
متن کاملConducting Randomized Controlled Trials for the Treatment of Enteric Fever
TO THE EDITOR—We read with great interest the recent article by Meltzer et al, “A Large Outbreak of Salmonella Paratyphi A Infection Among Israeli Travelers to Nepal” [1], and we would like to raise a few issues. The authors made the point that randomized controlled trials (RCTs) are difficult to conduct in developing countries. However, in Nepal, over the last decade we have carried out a seri...
متن کاملEfficacy dilution in randomized placebo-controlled vaginal microbicide trials
BACKGROUND To date different vaginal gel microbicides have been evaluated in phase 2b/3 trials, but none have demonstrated effectiveness for preventing HIV infection. Failure to demonstrate effectiveness however does not necessarily indicate that a product is truly inefficacious, as several sources of efficacy dilution may compromise our ability to identify products that may have been truly eff...
متن کاملCardiovascular Risk of Celecoxib in 6 Randomized Placebo - Controlled Trials
Scott D. Solomon, MD; Janet Wittes, PhD; Peter V. Finn, MD; Robert Fowler, MS; Jaye Viner, MD, MPH; Monica M. Bertagnolli, MD; Nadir Arber, MD; Bernard Levin, MD; Curtis L. Meinert, PhD; Barbara Martin, PhD; Joseph L. Pater, MD, MSc; Paul E. Goss, MD, PhD; Peter Lance, MD; Stefanie Obara, BS; Emily Y. Chew, MD; Jonghyeon Kim, PhD; Gretchen Arndt, MHSA; Ernest Hawk, MD, MPH; for the Cross Trial ...
متن کاملPlacebo controlled trials.
Researchers assessed the efficacy of varenicline (a licensed cigarette smoking cessation aid) in helping users of smokeless tobacco to quit. A double blind placebo controlled parallel group randomised controlled trial study design was used. The intervention was varenicline 1 mg twice daily. Treatment was delivered for 12 weeks, with 14 weeks’ follow-up afterwards. Participants were aged 18 year...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Indian Journal of Medical Research
سال: 2015
ISSN: 0971-5916
DOI: 10.4103/0971-5916.160724